Our findings demonstrate that genetic Oma1 ablation rescues glomerular disease phenotypes in podocyte-specific Phb2ko mice, resulting in improvements in lifespan, renal function, glomerulosclerosis, podocyte count, slit diaphragm length, slit diaphragm organization, as well as mitochondrial morphology. This evidence concerns the gene OMA1 and glomerular disorder.